XML 32 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 2 - Investments (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Jun. 30, 2017
Jun. 30, 2016
Mar. 31, 2016
Sep. 30, 2017
Sep. 30, 2016
Cost-method Investments, Other than Temporary Impairment         $ 93,000 $ 750,000
Proceeds From Issuance of Restricted Cash $ 372,000          
Gain (Loss) on Sale of Investments         $ 1,838,000
Lumense Inc. [Member]            
Cost-method Investments, Other than Temporary Impairment     $ 50,000 $ 700,000    
Cost Method Investments     $ 0 $ 50,000    
Final Inc. [Member]            
Cost-method Investments, Other than Temporary Impairment   $ 90,000        
Cost-method Investments, Other than Temporary Impairment, Percent of Investment Written-down   90.00%        
Privately-held Technology Company [Member]            
Cost Method Investments   $ 98,000        
Cost Method Investments, Percent Sold 91.00%          
Gain (Loss) on Sale of Investments $ 1,466,000